Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Enhancement of matrix metalloproteinase 2 and 9 inhibitory action of minocycline by aspirin: an approach to attenuate outcome of acute myocardial infarction in diabetes.

Bhatt LK, Veeranjaneyulu A.

Arch Med Res. 2014 Apr;45(3):203-9. doi: 10.1016/j.arcmed.2014.01.008. Epub 2014 Mar 4.

PMID:
24606818
2.

A therapeutic approach to treat cardiovascular dysfunction of diabetes.

Bhatt LK, Veeranjaneyulu A.

Exp Toxicol Pathol. 2012 Nov;64(7-8):847-53. doi: 10.1016/j.etp.2011.03.005. Epub 2011 Apr 6.

PMID:
21474293
3.

Potentiation of aspirin-induced cerebroprotection by minocycline: a therapeutic approach to attenuate exacerbation of transient focal cerebral ischaemia.

Bhatt LK, Addepalli V.

Diab Vasc Dis Res. 2012 Jan;9(1):25-34. doi: 10.1177/1479164111427753. Epub 2011 Nov 1.

PMID:
22045867
4.

Minocycline with aspirin: an approach to attenuate diabetic nephropathy in rats.

Kumar Bhatt L, Addepalli V.

Ren Fail. 2011;33(1):72-8. doi: 10.3109/0886022X.2010.528117.

PMID:
21219209
5.

Minocycline with aspirin: a therapeutic approach in the treatment of diabetic neuropathy.

Bhatt LK, Veeranjaneyulu A.

Neurol Sci. 2010 Dec;31(6):705-16. doi: 10.1007/s10072-010-0243-3. Epub 2010 Mar 6.

PMID:
20213226
7.

Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase.

Nagel S, Su Y, Horstmann S, Heiland S, Gardner H, Koziol J, Martinez-Torres FJ, Wagner S.

Brain Res. 2008 Jan 10;1188:198-206. Epub 2007 Nov 26.

PMID:
18031717
8.

Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats.

Bencsik P, Kupai K, Giricz Z, Görbe A, Pipis J, Murlasits Z, Kocsis GF, Varga-Orvos Z, Puskás LG, Csonka C, Csont T, Ferdinandy P.

Am J Physiol Heart Circ Physiol. 2010 Aug;299(2):H512-8. doi: 10.1152/ajpheart.00052.2010. Epub 2010 Jun 11.

PMID:
20543091
9.

Matrix metalloproteinase-2 is downregulated in sciatic nerve by streptozotocin induced diabetes and/or treatment with minocycline: Implications for nerve regeneration.

Ali S, Driscoll HE, Newton VL, Gardiner NJ.

Exp Neurol. 2014 Nov;261:654-65. doi: 10.1016/j.expneurol.2014.08.017. Epub 2014 Aug 23.

10.

Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective.

Bencsik P, Pálóczi J, Kocsis GF, Pipis J, Belecz I, Varga ZV, Csonka C, Görbe A, Csont T, Ferdinandy P.

Pharmacol Res. 2014 Feb;80:36-42. doi: 10.1016/j.phrs.2013.12.007. Epub 2013 Dec 28.

PMID:
24380772
11.

Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9.

Romanic AM, Harrison SM, Bao W, Burns-Kurtis CL, Pickering S, Gu J, Grau E, Mao J, Sathe GM, Ohlstein EH, Yue TL.

Cardiovasc Res. 2002 Jun;54(3):549-58.

PMID:
12031700
12.
13.

Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.

Yasuda S, Miyazaki S, Kinoshita H, Nagaya N, Kanda M, Goto Y, Nonogi H.

Clin Sci (Lond). 2007 Jan;112(1):43-9.

PMID:
16939410
14.

Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats.

Fan X, Lo EH, Wang X.

Stroke. 2013 Mar;44(3):745-52. doi: 10.1161/STROKEAHA.111.000309. Epub 2013 Feb 19.

16.

N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats.

Wang T, Qiao S, Lei S, Liu Y, Ng KF, Xu A, Lam KS, Irwin MG, Xia Z.

PLoS One. 2011;6(8):e23967. doi: 10.1371/journal.pone.0023967. Epub 2011 Aug 30.

17.

Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes.

Kelly-Cobbs AI, Prakash R, Li W, Pillai B, Hafez S, Coucha M, Johnson MH, Ogbi SN, Fagan SC, Ergul A.

Am J Physiol Heart Circ Physiol. 2013 Mar 15;304(6):H806-15. doi: 10.1152/ajpheart.00720.2012. Epub 2013 Jan 18.

18.

[Effects of pravastatin, fosinopril and their combination on myocardium TNF-alpha expression and ventricular remodeling after myocardial infarction in rats].

Wei M, Gu SM, Zhang YY, Wu YH, Wu ZG.

Zhonghua Xin Xue Guan Bing Za Zhi. 2005 May;33(5):444-7. Chinese.

PMID:
15932706
19.

Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.

Van Linthout S, Seeland U, Riad A, Eckhardt O, Hohl M, Dhayat N, Richter U, Fischer JW, Böhm M, Pauschinger M, Schultheiss HP, Tschöpe C.

Basic Res Cardiol. 2008 Jul;103(4):319-27. doi: 10.1007/s00395-008-0715-2. Epub 2008 Mar 17.

PMID:
18347835
20.

Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke.

Machado LS, Kozak A, Ergul A, Hess DC, Borlongan CV, Fagan SC.

BMC Neurosci. 2006 Jul 17;7:56.

Supplemental Content

Support Center